# HSCS (HeartSciences Inc.) - SEC EDGAR Financial Statements

> HeartSciences Inc. reported $4.5K in revenue and a net loss of $10.26M for the trailing twelve months ended July 31, 2026 (up 10.5% year over year), with a 60.9% gross margin and a -209733.1% operating margin.

- Canonical: https://convexityos.com/fundamentals/HSCS
- Markdown: https://convexityos.com/fundamentals/HSCS.md
- SEC CIK: 0001468492
- Reporting currency: USD
- Latest filing period: July 31, 2026
- Last synced: Nov 21, 2026, 05:06 UTC
- Primary source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001468492&type=&dateb=&owner=include&count=40)

## Key Financial Metrics

| Metric | Period | Value | Notes |
| --- | --- | --- | --- |
| Revenue | TTM | $4.5K | +10.5% YoY |
| Operating Income | TTM | -$9.48M | -209733.1% margin |
| Net Income | TTM | -$10.26M | -227024.2% net margin |
| Diluted EPS | TTM | -- | Split-adjusted |
| Free Cash Flow | TTM | -$7.43M | -164422.7% FCF margin |
| Cash & ST Investments | Jul 31, 2026 | $30K | Total debt: $282K |

## Income Statement

### Income Statement (Annual)

| Line Item | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
| --- | --- | --- | --- | --- | --- |
| **Revenue** | $4.3K | $4.3K | $19K | $5.2K | $14K |
| Cost of Revenue | $1.8K | $1.9K | $6.1K | $2.8K | $7.9K |
| **Gross Profit** | $2.6K | $2.5K | $13K | $2.4K | $6.5K |
| Research & Development | $2.84M | $4.39M | $2.88M | $2.46M | $3.00M |
| Selling, General & Admin | $5.58M | $3.97M | $3.44M | $3.65M | $1.71M |
| Total Operating Expenses | $8.42M | $8.36M | $6.32M | $6.12M | $4.72M |
| **Operating Income** | -$8.41M | -$8.35M | -$6.31M | -$6.11M | -$4.71M |
| **EBITDA** | -$8.39M | -$8.31M | -$6.28M | -$6.09M | -$4.68M |
| Interest Expense | $753K | $500K | $354K | $243K | $372K |
| Income Tax Expense | $0 | $0 | -- | -- | -- |
| **Net Income** | -$9.14M | -$8.77M | -$6.61M | -$6.35M | -$4.83M |
| Basic EPS | -$3.48 | -$9.34 | -$18.74 | -$80.00 | -$145.00 |
| **Diluted EPS** | -- | -$9.34 | -$18.74 | -$80.00 | -$145.00 |
| Basic Shares Outstanding | 2.6M | 938.3K | 352.5K | 79.5K | 33.2K |
| Diluted Shares Outstanding | -- | 938.3K | 352.5K | 79.5K | 33.2K |

### Income Statement (Quarterly)

| Line Item | Jul 2026 | Apr 2026 | Jan 2026 | Oct 2025 | Jul 2025 | Apr 2025 | Jan 2025 | Oct 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | $2.1K | $0 | $0 | $2.4K | $1.9K | -- | $0 | -- |
| Cost of Revenue | $760 | $0 | $0 | $1.0K | $760 | -- | $0 | -- |
| **Gross Profit** | $1.3K | $0 | $0 | $1.4K | $1.1K | -- | $0 | -- |
| Research & Development | $907K | $476K | $639K | $727K | $997K | $929K | $1.03M | $1.20M |
| Selling, General & Admin | $2.03M | $2.06M | $1.29M | $1.35M | $878K | $994K | $1.34M | $786K |
| Total Operating Expenses | $2.94M | $2.54M | $1.93M | $2.07M | $1.88M | $1.92M | $2.37M | $1.99M |
| **Operating Income** | -$2.94M | -$2.54M | -$1.93M | -$2.07M | -$1.87M | -$1.92M | -$2.37M | -$1.99M |
| **EBITDA** | -$2.93M | -$2.53M | -$1.92M | -$2.07M | -$1.87M | -$1.91M | -$2.37M | -$1.97M |
| Interest Expense | $235K | $228K | $62K | $280K | $184K | $181K | $179K | $118K |
| **Net Income** | -$3.17M | -$2.75M | -$1.99M | -$2.35M | -$2.05M | -$2.09M | -$2.54M | -$2.08M |
| Basic EPS | -$0.86 | -- | -$0.63 | -$0.85 | -$1.58 | -- | -$2.57 | -$2.27 |
| **Diluted EPS** | -- | -- | -- | -$0.85 | -$1.58 | -- | -$2.57 | -$2.27 |
| Basic Shares Outstanding | 3.7M | -- | 3.2M | 2.8M | 1.3M | -- | 986.1K | 917.4K |
| Diluted Shares Outstanding | -- | -- | -- | 2.8M | 1.3M | -- | 986.1K | 917.4K |

## Balance Sheet

### Balance Sheet (Annual)

| Line Item | FY 2026 | FY 2025 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
| --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $1.66M | $1.10M | $1.10M | $5.81M | $1.66M | $918K |
| **Cash & Short-Term Investments** | $1.66M | $1.10M | $1.10M | $5.81M | $1.66M | $918K |
| Accounts Receivable, Net | $0 | $4.3K | $4.3K | -- | -- | $2.3K |
| Inventory | $656K | $650K | $650K | $629K | $676K | $674K |
| Other Current Assets | $40K | $40K | $40K | $40K | $40K | $40K |
| **Total Current Assets** | $2.58M | $2.17M | $2.17M | $7.35M | $2.70M | $1.93M |
| Property, Plant & Equipment, Net | $39K | $64K | $64K | $98K | $61K | $70K |
| Intangible Assets | $1.66M | $1.62M | $1.62M | $1.59M | -- | -- |
| **Total Non-Current Assets** | $2.68M | $2.05M | $2.05M | $2.15M | $591K | $159K |
| **Total Assets** | $5.26M | $4.22M | $4.22M | $9.50M | $3.29M | $2.09M |
| Accounts Payable | $318K | $319K | $319K | $448K | $631K | $695K |
| Other Current Liabilities | $21K | $30K | $30K | $34K | $49K | $1.2K |
| **Total Current Liabilities** | $4.86M | $3.70M | $3.70M | $1.75M | $1.83M | $3.47M |
| **Total Non-Current Liabilities** | $176K | $315K | $315K | $434K | $1.22M | $4.67M |
| **Total Liabilities** | $5.04M | $4.02M | $4.02M | $2.19M | $3.06M | $8.15M |
| **Total Debt (incl. Leases)** | $315K | $434K | $434K | $536K | $566K | $91K |
| Common Stock | $3.2K | $1.1K | $1.1K | $677 | $101 | $3.3K |
| Retained Earnings | -$85.27M | -$76.13M | -$76.13M | -$67.36M | -$60.76M | -$54.40M |
| **Total Stockholders' Equity** | $226K | $205K | $205K | $7.32M | $231K | -$6.06M |
| Total Equity | $226K | $205K | $205K | $7.32M | $231K | -$6.06M |

### Balance Sheet (Quarterly)

| Line Item | Jul 2026 | Jun 2026 | Apr 2026 | Jan 2026 | Dec 2025 | Oct 2025 | Jul 2025 | Apr 2025 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $30K | $1.66M | $1.66M | $3.40M | $1.10M | $1.95M | $2.79M | $1.10M |
| **Cash & Short-Term Investments** | $30K | $1.66M | $1.66M | $3.40M | $1.10M | $1.95M | $2.79M | $1.10M |
| Accounts Receivable, Net | -- | $0 | -- | $0 | $4.3K | -- | -- | $4.3K |
| Inventory | $403K | $656K | $656K | $657K | $650K | $657K | $650K | $650K |
| Other Current Assets | $40K | $40K | $40K | $40K | $40K | $258K | $40K | $40K |
| **Total Current Assets** | $812K | $2.58M | $2.58M | $5.10M | $2.17M | $3.79M | $4.42M | $2.17M |
| Property, Plant & Equipment, Net | $33K | $39K | $39K | $46K | $64K | $53K | $56K | $64K |
| Intangible Assets | $1.66M | $1.66M | $1.66M | $1.66M | $1.62M | $1.63M | $1.62M | $1.62M |
| **Total Non-Current Assets** | $2.93M | $2.68M | $2.68M | $2.46M | $2.05M | $2.20M | $2.02M | $2.05M |
| **Total Assets** | $3.74M | $5.26M | $5.26M | $7.55M | $4.22M | $6.00M | $6.44M | $4.22M |
| Accounts Payable | $1.02M | $318K | $318K | $411K | $319K | $317K | $283K | $319K |
| Other Current Liabilities | $181K | $21K | $21K | $85K | $30K | $149K | $215K | $30K |
| **Total Current Liabilities** | $5.63M | $4.86M | $4.86M | $4.27M | $3.70M | $1.57M | $3.01M | $3.70M |
| **Total Non-Current Liabilities** | $137K | $176K | $176K | $633K | $315K | $247K | $282K | $315K |
| **Total Liabilities** | $5.77M | $5.04M | $5.04M | $4.90M | $4.02M | $1.81M | $3.30M | $4.02M |
| **Total Debt (incl. Leases)** | $282K | $315K | $315K | $346K | $434K | $376K | $406K | $434K |
| Common Stock | $3.9K | $3.2K | $3.2K | $3.2K | $1.1K | $3.1K | $2.3K | $1.1K |
| Retained Earnings | -$88.44M | -$85.27M | -$85.27M | -$82.52M | -$76.13M | -$80.53M | -$78.18M | -$76.13M |
| **Total Stockholders' Equity** | -$2.03M | $226K | $226K | $2.65M | $205K | $4.18M | $3.14M | $205K |
| Total Equity | -$2.03M | $226K | $226K | $2.65M | $205K | $4.18M | $3.14M | $205K |

## Cash Flow Statement

### Cash Flow Statement (Annual)

| Line Item | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
| --- | --- | --- | --- | --- | --- |
| Net Income | -$9.14M | -$8.77M | -$6.61M | -$6.35M | -$4.83M |
| Depreciation & Amortization | $28K | $38K | $28K | $27K | $27K |
| Stock-Based Compensation | $1.31M | $250K | $405K | $248K | $68K |
| Change in Receivables | $4.3K | -$4.3K | -- | $2.3K | $2.3K |
| Change in Inventory | -$5.4K | -$21K | $47K | -$2.2K | $77K |
| Change in Payables | -$334 | -$130K | -$183K | $38K | $359K |
| **Operating Cash Flow** | -$7.43M | -$7.41M | -$6.07M | -$5.77M | -$3.64M |
| Capital Expenditure | -$3.6K | -$3.2K | -$64K | -$18K | -$1.9K |
| **Free Cash Flow** | -$7.43M | -$7.42M | -$6.13M | -$5.79M | -$3.65M |
| **Investing Cash Flow** | -$44K | -$30K | -$125K | -$18K | -$1.9K |
| Common Stock Issued | $173K | $1.15M | -- | $5.19M | -- |
| **Financing Cash Flow** | $8.03M | $2.73M | $10.34M | $6.53M | $3.84M |
| **Net Change in Cash** | $559K | -$4.71M | $4.15M | $742K | $195K |

### Cash Flow Statement (Quarterly)

| Line Item | Jul 2026 | Apr 2026 | Jan 2026 | Oct 2025 | Jul 2025 | Apr 2025 | Jan 2025 | Oct 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$3.17M | -$2.75M | -$1.99M | -$2.35M | -$2.05M | -$2.09M | -$2.54M | -$2.08M |
| Depreciation & Amortization | $6.3K | $6.8K | $6.9K | $7.0K | $7.1K | $7.5K | $6.0K | $12K |
| Stock-Based Compensation | $739K | $325K | $376K | $437K | $175K | $96K | $55K | $45K |
| Change in Receivables | $0 | $0 | $0 | $0 | $4.3K | -- | -- | -- |
| Change in Inventory | $760 | $1.7K | $0 | -$7.8K | $760 | $1.9K | $760 | -$9.9K |
| Change in Payables | $704K | -$92K | $93K | $34K | -$35K | -$86K | $128K | -$120K |
| **Operating Cash Flow** | -$1.32M | -$1.68M | -$1.46M | -$2.33M | -$1.95M | -$1.59M | -$1.62M | -$2.18M |
| **Investing Cash Flow** | -$280K | $0 | -$28K | -$16K | -$814 | -$7.8K | -$16K | -$5.8K |
| Common Stock Issued | $10K | $0 | -- | -- | $0 | -- | -- | -- |
| **Financing Cash Flow** | -$28K | -$64K | $2.94M | $1.51M | $3.65M | $100K | $180K | $1.90M |
| **Net Change in Cash** | -$1.63M | -$1.74M | $1.45M | -$841K | $1.69M | -$1.50M | -$1.46M | -$288K |

## Profitability Ratios & YoY Growth

### Profitability Ratios & YoY Growth (Annual)

| Line Item | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
| --- | --- | --- | --- | --- | --- |
| **Gross Margin** | 59.1% | 56.8% | 67.3% | 45.7% | 45.1% |
| **Operating Margin** | -194787.4% | -192013.1% | -33902.0% | -118698.3% | -32765.6% |
| **Net Profit Margin** | -211666.5% | -201499.5% | -35511.9% | -123384.3% | -33592.6% |
| Return on Equity (ROE) | -- | -4272.2% | -90.3% | -2756.1% | -- |
| Return on Assets (ROA) | -- | -207.6% | -69.5% | -193.3% | -231.1% |
| Current Ratio | -- | 0.59x | 4.20x | 1.47x | 0.56x |
| Quick Ratio | -- | 0.41x | 3.84x | 1.10x | 0.36x |
| Debt to Equity | -- | 2.12x | 0.07x | 2.45x | -- |
| **Revenue Growth (YoY)** | -0.7% | -76.6% | +261.2% | -64.2% | -- |
| Gross Profit Growth (YoY) | +3.3% | -80.3% | +431.8% | -63.7% | -- |

### Profitability Ratios & YoY Growth (Quarterly)

| Line Item | Jul 2026 | Apr 2026 | Jan 2026 | Oct 2025 | Jul 2025 | Apr 2025 | Jan 2025 | Oct 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Gross Margin** | 60.9% | 59.1% | -- | -- | -- | -- | -- | -- |
| **Operating Margin** | -209733.1% | -194787.4% | -- | -- | -- | -- | -- | -- |
| **Net Profit Margin** | -227024.2% | -211666.5% | -- | -- | -- | -- | -- | -- |
| Return on Equity (ROE) | -- | -4044.0% | -319.9% | -216.1% | -279.2% | -4272.2% | -476.7% | -189.8% |
| Return on Assets (ROA) | -274.5% | -173.7% | -112.3% | -150.7% | -136.2% | -207.6% | -149.3% | -98.0% |
| Current Ratio | 0.14x | 0.53x | 1.19x | 2.42x | 1.47x | 0.59x | 1.02x | 1.72x |
| Quick Ratio | 0.07x | 0.40x | 1.04x | 2.00x | 1.25x | 0.41x | 0.83x | 1.52x |
| Debt to Equity | -- | 1.39x | 0.13x | 0.09x | 0.13x | 2.12x | 0.26x | 0.12x |
| **Revenue Growth (YoY)** | +10.5% | -- | -- | -- | -- | -- | -100.0% | -- |
| Gross Profit Growth (YoY) | +17.5% | -- | -- | -- | -- | -- | -100.0% | -- |

## Related Companies

[AMZN (Amazon.com, Inc.)](https://convexityos.com/fundamentals/AMZN), [WMT (Walmart Inc.)](https://convexityos.com/fundamentals/WMT), [AAPL (Apple Inc.)](https://convexityos.com/fundamentals/AAPL), [GOOG (Alphabet Inc.)](https://convexityos.com/fundamentals/GOOG), [UNH (UnitedHealth Group Incorporated)](https://convexityos.com/fundamentals/UNH), [CVS (CVS HEALTH Corp)](https://convexityos.com/fundamentals/CVS), [MCK (McKESSON CORPORATION)](https://convexityos.com/fundamentals/MCK), [BRK-A (Berkshire Hathaway Inc.)](https://convexityos.com/fundamentals/BRK-A)

---

## About Convexity

Published by [Convexity](https://convexityos.com/), a primary-source financial intelligence terminal built on SEC EDGAR filings, XBRL financial statements, options, macro data, and cited AI research. Free tier with no card and published prices at https://convexityos.com/pricing; Streamable HTTP MCP server at https://convexityos.com/mcp; full site index at https://convexityos.com/llms.txt.
